Severe Adverse Toxic Effects of Low-Dose Methotrexate Treatment on an Ectopic Pregnancy Patient With Methylenetetrahydrofolate Reductase Mutations: A Case Report
Background: Low-dose methylenetetrahydrofolate (LD-MTX) has been widely used for the treatment of the ectopic pregnancy (EP) for many decades, and related severe adverse toxic effects are rare. Current studies have shown that the polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene can...
Guardado en:
Autores principales: | Huan Yu, Wenhui Wang, Haiyan Liang, Kun Wang, Bin Ling |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ee42bffbd6244979c907aca772341f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY
por: Mussarat Sultana, et al.
Publicado: (2020) -
Associations of Genetic Variants of Methylenetetrahydrofolate Reductase and Serum Folate Levels with Metabolic Parameters in Patients with Schizophrenia
por: Chun-Hsin Chen, et al.
Publicado: (2021) -
Effects of methylenetetrahydrofolate reductase single-nucleotide polymorphisms on breast, cervical, ovarian, and endometrial cancer susceptibilities
por: Zheng Wang, et al.
Publicado: (2021) -
Fertility outcomes subsequent to medical and surgical treatment for ectopic pregnancy: A retrospective cohort study in Iran
por: Zahra Asgari, et al.
Publicado: (2021) -
Associations Between Gestational Diabetes Mellitus Risk and Folate Status in Early Pregnancy and MTHFR C677T Polymorphisms in Chinese Women
por: Liu PJ, et al.
Publicado: (2020)